We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTM
851
ZoomInfo Technologies
GTM
$973M
| $532K | ﹤0.01% |
+52,604
| New | +$487K |
|
852
Brown-Forman Class B
BF.B
$13.2B
| $530K | ﹤0.01% |
19,700
+4,314
| +28% | +$138K |
|
853
N-able
NABL
$882M
| $527K | ﹤0.01% |
65,084
+23,001
| +55% | +$172K |
|
854
ManpowerGroup
MAN
$2.44B
| $520K | ﹤0.01% |
+12,863
| New | +$562K |
|
855
ADT
ADT
$5.58B
| $503K | ﹤0.01% |
+59,372
| New | +$486K |
|
856
Alkami Technology
ALKT
$1.94B
| $502K | ﹤0.01% |
+16,641
| New | +$463K |
|
857
Applovin
APP
$133B
| $488K | ﹤0.01% |
+1,393
| New | +$452K |
|
858
Unity
U
$13.8B
| $483K | ﹤0.01% |
+19,976
| New | +$440K |
|
859
Criteo S.A. Ordinary Shares
CRTO
$1.1B
| $480K | ﹤0.01% |
+20,029
| New | +$564K |
|
860
AppFolio
APPF
$6.38B
| $477K | ﹤0.01% |
2,070
+316
| +18% | +$68.9K |
|
861
SentinelOne
S
$6.53B
| $448K | ﹤0.01% |
24,488
+3,483
| +17% | +$63.7K |
|
862
Context Therapeutics
CNTX
$55.1M
| $446K | ﹤0.01% |
680,188
-681,000
| -50% | -$490K |
|
863
Globant
GLOB
$1.58B
| $445K | ﹤0.01% |
+4,895
| New | +$523K |
|
|
CWAN
864
DELISTED
Clearwater Analytics
CWAN
| $436K | ﹤0.01% |
19,892
-174
| -0.9% | -$4K |
|
|
SLDE
865
Slide Insurance Holdings
SLDE
$2.33B
| $433K | ﹤0.01% |
+20,000
| New | +$431K |
|
866
Northrop Grumman
NOC
$77.1B
| $428K | ﹤0.01% |
857
-1,659
| -66% | -$816K |
|
|
ARTV
867
Artiva Biotherapeutics
ARTV
$491M
| $428K | ﹤0.01% |
283,124
| – | – |
|
868
Insperity
NSP
$1.93B
| $418K | ﹤0.01% |
+6,961
| New | +$486K |
|
869
News Corp Class B
NWS
$16.9B
| $413K | ﹤0.01% |
12,041
+2,603
| +28% | +$82.5K |
|
870
F5
FFIV
$22.9B
| $411K | ﹤0.01% |
1,395
-111,552
| -99% | -$30.8M |
|
871
Ubiquiti
UI
$33.7B
| $408K | ﹤0.01% |
991
-223
| -18% | -$81.2K |
|
872
Appian
APPN
$1.98B
| $406K | ﹤0.01% |
+13,585
| New | +$408K |
|
873
MKS Inc
MKSI
$20.1B
| $404K | ﹤0.01% |
+4,067
| New | +$331K |
|
874
Elastic
ESTC
$6.84B
| $403K | ﹤0.01% |
+4,780
| New | +$404K |
|
875
LiveRamp
RAMP
$2.3B
| $395K | ﹤0.01% |
11,956
-1,262
| -10% | -$36.7K |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.